Literature DB >> 12714816

Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis.

Bekir Kocazeybek1, Serdar Küçükoğlu, Y Ali Oner.   

Abstract

BACKGROUND: The aim of this study was to investigate the diagnostic values of serum procalcitonin (PCT) and C-reactive protein (CRP) levels in infective endocarditis (IE) and to correlate them with the etiology of the disease and the prognosis of the patients.
METHODS: Fifty patients who were diagnosed as having IE based on Duke criteria (major and/or minor) were included in the study at the Istanbul University Cardiology Institute and Florence Nightingale Hospital. Forty patients with bacteremia (non-IE) and 50 healthy blood donors were also included in the study as the control group. During the 45 days of medical follow-up, in those patients who had a response to medical therapy based on the results of left ventricular function tests, transesophageal echocardiography (TEE) and culture, among other factors, PCT and CRP levels were measured in 5-cm(3) blood samples obtained without anticoagulant when they were first admitted (day 0), as well as 24 h and 15, 30 and 45 days after admission. In the patients who had valve replacement, 5-cm(3) blood samples without anticoagulant were similarly obtained on the day of admission, after 24 h and/or on the 15th day, and 1 day before and on the 2nd and 5th days after the operation.
RESULTS: In this study, a significant difference (p < 0.001) was found between the IE group and the healthy control group with respect to their serum PCT and CRP levels at the time of admission. No significant difference was found between IE and non-IE groups (p > 0.05). The sensitivity of PCT in comparison to CRP was found to be lower (84 vs. 100%); however, its specificity was determined to be higher (88 vs. 72%). The median values of serum PCT in the nonoperated and operated cases at the time of admission, after 24 h and on the 15th day were 3.71, 5.35 and 0.44, and 2.45, 4.28 and 4.22 ng/ml, respectively, and those of CRP were 9.30, 10.95 and 10.65, and 9.5, 10.9 and 10.2 mg/dl, respectively. The median values of serum PCT were found to be higher in cases with IE and non-IE related to gram-negative bacteria than those related to gram-positive bacteria (p < 0.02). This was found to be insignificant for CRP (p > 0.05).
CONCLUSIONS: As a result, this study suggests that in the diagnosis of IE, it would be beneficial to use PCT, besides TEE, culture and other clinical criteria, for its high specificity and positive predictive value in comparison to CRP. This study also suggests that in determining the response to medical treatment in the follow-up period, PCT could be a more valuable parameter than CRP, as PCT has a high prognostic value and is a good indicator for valve replacement in addition to the major criteria. Furthermore, serum PCT levels may help the physician to decide on the antimicrobial therapy combination before obtaining the culture results, or in situations in which the agent could not be isolated yet. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714816     DOI: 10.1159/000069777

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  19 in total

1.  Inflammatory biomarkers in infective endocarditis: machine learning to predict mortality.

Authors:  T Ris; A Teixeira-Carvalho; R Matos Pinto Coelho; C Brandao-de-Resende; M Souza Gomes; L Rodrigues Amaral; P H Oliveira Murta Pinto; L J Souza Santos; J Teixeira Salles; Jolien Roos-Hesselink; N Verkaik; T Cristina Abreu Ferrari; M C Pereira Nunes
Journal:  Clin Exp Immunol       Date:  2019-02-17       Impact factor: 4.330

2.  Association of mean platelet volume level with in-hospital major adverse events in infective endocarditis.

Authors:  Duran Tok; Uğur Canpolat; Derya Tok; Osman Turak; Ahmet İşleyen; Fatih Öksüz; Mehmet Ali Mendi; Kumral Çağlı; Fatma Nurcan Başar; Zehra Gölbaşı
Journal:  Wien Klin Wochenschr       Date:  2015-03-17       Impact factor: 1.704

3.  Usefulness of procalcitonin for diagnosis of infective endocarditis.

Authors:  Matjaz Jereb; Tadeja Kotar; Tomaz Jurca; Tatjana Lejko Zupanc
Journal:  Intern Emerg Med       Date:  2009-04-09       Impact factor: 3.397

4.  Serum procalcitonin has the potential to identify Staphylococcus aureus endocarditis.

Authors:  F Cuculi; S Toggweiler; M Auer; Ch Auf der Maur; M Zuber; P Erne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-03       Impact factor: 3.267

5.  Extension of antimicrobial treatment in patients with left-sided native valve endocarditis based on elevated C-reactive protein values.

Authors:  D W M Verhagen; J Hermanides; J C Korevaar; P M M Bossuyt; R B A van den Brink; P Speelman; J T M van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

6.  Unilateral pulmonary edema in acute aortic regurgitation: A complication of infective endocarditis.

Authors:  Rana Al-Zakhari; Maham Suhail; Mays Yousif; Bhavesh Gala; Keith Diaz
Journal:  J Cardiol Cases       Date:  2021-01-18

7.  Urinary biomarker of oxidative stress correlating with outcome in critically septic patients.

Authors:  Wei-Erh Cheng; Chuen-Ming Shih; Liang-Wen Hang; Kuen-Yuh Wu; Hsin-Ling Yang; Wu-Huei Hsu; Te-Chun Hsia
Journal:  Intensive Care Med       Date:  2007-04-11       Impact factor: 17.440

Review 8.  Mechanisms of infective endocarditis: pathogen-host interaction and risk states.

Authors:  Karl Werdan; Sebastian Dietz; Bettina Löffler; Silke Niemann; Hasan Bushnaq; Rolf-Edgar Silber; Georg Peters; Ursula Müller-Werdan
Journal:  Nat Rev Cardiol       Date:  2013-11-19       Impact factor: 32.419

9.  Evaluation of vitreous Procalcitonin as a diagnostic biomarker in infectious endophthalmitis.

Authors:  Poonam Naik; Gagan Satyashree; Ashik Mohamed; Taraprasad Das; Vivek Pravin Dave; Joveeta Joseph
Journal:  Int Ophthalmol       Date:  2021-05-24       Impact factor: 2.031

10.  Cystatin C in a composite risk score for mortality in patients with infective endocarditis: a cohort study.

Authors:  Christian Bjurman; Ulrika Snygg-Martin; Lars Olaison; Michael L X Fu; Ola Hammarsten
Journal:  BMJ Open       Date:  2012-07-12       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.